Neurological adverse events of mitotane in adrenocortical carcinoma: results of a pilot study

Overview of attention for article published in Frontiers in oncology, August 2023

Altmetric Badge

Mentioned by

twitter: 2 X users

Readers on

mendeley: 3 Mendeley

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 18,691 followers.

RT @FrontOncology: New research: Neurological adverse events of mitotane in adrenocortical carcinoma: results of a pilot study: Introductio…

22 Aug 2023

Reply Repost Favourite

New research: Neurological adverse events of mitotane in adrenocortical carcinoma: results of a pilot study: Introduction Mitotane, the only drug approved by the Food and Drug Administration (FDA) for the treatment of adrenocortical carcinoma,… #oncology

21 Aug 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.